Roivant Sciences Ltd
F:87S
Roivant Sciences Ltd
F:87S
Price:
18.38
EUR
-0.68%
Market Closed
Market Cap:
€13.6B
Balance Sheet
Balance Sheet Decomposition
Roivant Sciences Ltd
Roivant Sciences Ltd
Balance Sheet Decomposition is not available for
Roivant Sciences Ltd
Roivant Sciences Ltd
Balance Sheet
Roivant Sciences Ltd
Roivant Sciences Ltd
Currency: USD
| Mar-2020 | Mar-2021 | Mar-2022 | Mar-2023 | Mar-2024 | Mar-2025 | ||
|---|---|---|---|---|---|---|---|
| Assets | |||||||
| Cash & Cash Equivalents |
2 183
|
2 055
|
2 060
|
1 677
|
6 536
|
2 715
|
|
| Cash |
0
|
0
|
0
|
0
|
0
|
94
|
|
| Cash Equivalents |
2 183
|
2 055
|
2 060
|
1 677
|
6 536
|
2 621
|
|
| Short-Term Investments |
0
|
0
|
0
|
0
|
0
|
2 171
|
|
| Total Receivables |
15
|
14
|
0
|
33
|
83
|
0
|
|
| Accounts Receivables |
9
|
11
|
0
|
30
|
54
|
0
|
|
| Other Receivables |
7
|
3
|
0
|
2
|
29
|
0
|
|
| Inventory |
0
|
0
|
0
|
3
|
35
|
0
|
|
| Other Current Assets |
21
|
118
|
86
|
86
|
78
|
113
|
|
| Total Current Assets |
2 219
|
2 187
|
2 147
|
1 799
|
6 732
|
5 000
|
|
| PP&E Net |
74
|
77
|
87
|
92
|
66
|
101
|
|
| Intangible Assets |
0
|
0
|
0
|
145
|
138
|
0
|
|
| Long-Term Investments |
93
|
290
|
326
|
304
|
248
|
303
|
|
| Other Long-Term Assets |
90
|
36
|
26
|
50
|
39
|
33
|
|
| Total Assets |
2 477
N/A
|
2 590
+5%
|
2 585
0%
|
2 390
-8%
|
7 222
+202%
|
5 437
-25%
|
|
| Liabilities | |||||||
| Accounts Payable |
10
|
21
|
35
|
38
|
53
|
24
|
|
| Accrued Liabilities |
77
|
89
|
139
|
179
|
185
|
124
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
|
| Current Portion of Long-Term Debt |
0
|
0
|
0
|
43
|
12
|
0
|
|
| Other Current Liabilities |
5
|
109
|
11
|
13
|
16
|
2
|
|
| Total Current Liabilities |
92
|
219
|
184
|
272
|
267
|
149
|
|
| Long-Term Debt |
109
|
170
|
210
|
379
|
431
|
0
|
|
| Minority Interest |
77
|
264
|
405
|
450
|
480
|
500
|
|
| Other Liabilities |
168
|
138
|
129
|
131
|
77
|
100
|
|
| Total Liabilities |
445
N/A
|
792
+78%
|
928
+17%
|
1 232
+33%
|
1 254
+2%
|
749
-40%
|
|
| Equity | |||||||
| Common Stock |
0
|
0
|
0
|
0
|
0
|
0
|
|
| Retained Earnings |
1 109
|
1 919
|
2 764
|
3 773
|
576
|
116
|
|
| Additional Paid In Capital |
3 144
|
3 815
|
4 422
|
4 933
|
5 396
|
4 562
|
|
| Other Equity |
2
|
99
|
1
|
3
|
4
|
9
|
|
| Total Equity |
2 032
N/A
|
1 798
-12%
|
1 657
-8%
|
1 158
-30%
|
5 969
+416%
|
4 688
-21%
|
|
| Total Liabilities & Equity |
2 477
N/A
|
2 590
+5%
|
2 585
0%
|
2 390
-8%
|
7 222
+202%
|
5 437
-25%
|
|
| Shares Outstanding | |||||||
| Common Shares Outstanding |
685
|
685
|
695
|
760
|
807
|
696
|
|
Switch to:
Switch to:
See Also
Discover More
